NewSquare Capital’s Meridian Bioscience Inc VIVO Stock Holding History

NewSquare Capital’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20	Closed	-$664	–	970
2022 Q4	$664	Buy	+20	New	+$644	﹤0.01%	626

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

NewSquare Capital's VIVO Position: Q1 2023 in Review

NewSquare Capital sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 20 shares — an estimated $664 sold.

NewSquare Capital first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $664 in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

NewSquare Capital reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
NewSquare Capital sold 20 Meridian Bioscience Inc shares in Q1 2023, an estimated $664.
NewSquare Capital first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
NewSquare Capital's Meridian Bioscience Inc position peaked at $664 in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on NewSquare Capital's 13F filing for Q1 2023, filed 1 May 2023.